Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
SIGA vs AGEN
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
SIGA vs AGEN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
| Market Cap | $337M | $137M |
| Revenue (TTM) | $95M | $114M |
| Net Income (TTM) | $23M | $115K |
| Gross Margin | 68.6% | 35.7% |
| Operating Margin | 25.1% | -17.7% |
| Forward P/E | 2.8x | 1.9x |
| Total Debt | $795K | $10M |
| Cash & Equiv. | $154.97T | $3M |
SIGA vs AGEN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SIGA Technologies, … (SIGA) | 100 | 78.5 | -21.5% |
| Agenus Inc. (AGEN) | 100 | 5.2 | -94.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SIGA vs AGEN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SIGA is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 4 yrs, beta 1.15, yield 12.8%
- 7.2% 10Y total return vs AGEN's -93.5%
- Lower volatility, beta 1.15, Low D/E 0.0%, current ratio 11.83x
AGEN carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 10.4%, EPS growth 100.0%, 3Y rev CAGR 5.2%
- 10.4% revenue growth vs SIGA's -31.8%
- Lower P/E (1.9x vs 2.8x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% revenue growth vs SIGA's -31.8% | |
| Value | Lower P/E (1.9x vs 2.8x) | |
| Quality / Margins | 24.6% margin vs AGEN's 0.1% | |
| Stability / Safety | Beta 1.15 vs AGEN's 2.72 | |
| Dividends | 12.8% yield; 4-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +31.0% vs SIGA's +0.6% | |
| Efficiency (ROA) | 0.1% ROA vs SIGA's 0.0% |
SIGA vs AGEN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SIGA vs AGEN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SIGA leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AGEN and SIGA operate at a comparable scale, with $114M and $95M in trailing revenue. SIGA is the more profitable business, keeping 24.6% of every revenue dollar as net income compared to AGEN's 0.1%. On growth, AGEN holds the edge at +27.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $95M | $114M |
| EBITDAEarnings before interest/tax | $24M | -$10M |
| Net IncomeAfter-tax profit | $23M | $115,000 |
| Free Cash FlowCash after capex | $49M | -$159M |
| Gross MarginGross profit ÷ Revenue | +68.6% | +35.7% |
| Operating MarginEBIT ÷ Revenue | +25.1% | -17.7% |
| Net MarginNet income ÷ Revenue | +24.6% | +0.1% |
| FCF MarginFCF ÷ Revenue | +51.5% | -139.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -95.3% | +27.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -111.8% | +85.3% |
Valuation Metrics
AGEN leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $337M | $137M |
| Enterprise ValueMkt cap + debt − cash | -$154.97T | $145M |
| Trailing P/EPrice ÷ TTM EPS | 14.24x | -1144.12x |
| Forward P/EPrice ÷ next-FY EPS est. | 2.76x | 1.85x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | -6387033.21x | — |
| Price / SalesMarket cap ÷ Revenue | 3.56x | 1.20x |
| Price / BookPrice ÷ Book value/share | 0.00x | — |
| Price / FCFMarket cap ÷ FCF | 6.91x | — |
Profitability & Efficiency
Evenly matched — SIGA and AGEN each lead in 2 of 4 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), AGEN scores 6/9 vs SIGA's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | 0.0% | — |
| ROA (TTM)Return on assets | 0.0% | +0.1% |
| ROICReturn on invested capital | +0.0% | — |
| ROCEReturn on capital employed | 0.0% | — |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.00x | — |
| Net DebtTotal debt minus cash | -$154.97T | $7M |
| Cash & Equiv.Liquid assets | $154.97T | $3M |
| Total DebtShort + long-term debt | $795,169 | $10M |
| Interest CoverageEBIT ÷ Interest expense | — | 1.11x |
Total Returns (Dividends Reinvested)
SIGA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SIGA five years ago would be worth $10,096 today (with dividends reinvested), compared to $690 for AGEN. Over the past 12 months, AGEN leads with a +31.0% total return vs SIGA's +0.6%. The 3-year compound annual growth rate (CAGR) favors SIGA at 6.8% vs AGEN's -50.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -15.5% | +20.4% |
| 1-Year ReturnPast 12 months | +0.6% | +31.0% |
| 3-Year ReturnCumulative with dividends | +21.7% | -87.8% |
| 5-Year ReturnCumulative with dividends | +1.0% | -93.1% |
| 10-Year ReturnCumulative with dividends | +722.2% | -93.5% |
| CAGR (3Y)Annualised 3-year return | +6.8% | -50.4% |
Risk & Volatility
Evenly matched — SIGA and AGEN each lead in 1 of 2 comparable metrics.
Risk & Volatility
SIGA is the less volatile stock with a 1.15 beta — it tends to amplify market swings less than AGEN's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AGEN currently trades 53.0% from its 52-week high vs SIGA's 48.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.15x | 2.72x |
| 52-Week HighHighest price in past year | $9.62 | $7.34 |
| 52-Week LowLowest price in past year | $4.29 | $2.71 |
| % of 52W HighCurrent price vs 52-week peak | +48.9% | +53.0% |
| RSI (14)Momentum oscillator 0–100 | 44.0 | 54.7 |
| Avg Volume (50D)Average daily shares traded | 683K | 800K |
Analyst Outlook
SIGA leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates SIGA as "Buy" and AGEN as "Buy". SIGA is the only dividend payer here at 12.81% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $7.33 |
| # AnalystsCovering analysts | 1 | 11 |
| Dividend YieldAnnual dividend ÷ price | +12.8% | — |
| Dividend StreakConsecutive years of raises | 4 | 1 |
| Dividend / ShareAnnual DPS | $0.60 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% |
SIGA leads in 3 of 6 categories (Income & Cash Flow, Total Returns). AGEN leads in 1 (Valuation Metrics). 2 tied.
SIGA vs AGEN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is SIGA or AGEN a better buy right now?
For growth investors, Agenus Inc.
(AGEN) is the stronger pick with 10. 4% revenue growth year-over-year, versus -31. 8% for SIGA Technologies, Inc. (SIGA). SIGA Technologies, Inc. (SIGA) offers the better valuation at 14. 2x trailing P/E (2. 8x forward), making it the more compelling value choice. Analysts rate SIGA Technologies, Inc. (SIGA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SIGA or AGEN?
On forward P/E, Agenus Inc.
is actually cheaper at 1. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SIGA or AGEN?
Over the past 5 years, SIGA Technologies, Inc.
(SIGA) delivered a total return of +1. 0%, compared to -93. 1% for Agenus Inc. (AGEN). Over 10 years, the gap is even starker: SIGA returned +722. 2% versus AGEN's -93. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SIGA or AGEN?
By beta (market sensitivity over 5 years), SIGA Technologies, Inc.
(SIGA) is the lower-risk stock at 1. 15β versus Agenus Inc. 's 2. 72β — meaning AGEN is approximately 137% more volatile than SIGA relative to the S&P 500.
05Which is growing faster — SIGA or AGEN?
By revenue growth (latest reported year), Agenus Inc.
(AGEN) is pulling ahead at 10. 4% versus -31. 8% for SIGA Technologies, Inc. (SIGA). On earnings-per-share growth, the picture is similar: Agenus Inc. grew EPS 100. 0% year-over-year, compared to -60. 2% for SIGA Technologies, Inc.. Over a 3-year CAGR, AGEN leads at 5. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SIGA or AGEN?
SIGA Technologies, Inc.
(SIGA) is the more profitable company, earning 24. 6% net margin versus 0. 1% for Agenus Inc. — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIGA leads at 25. 1% versus -18. 0% for AGEN. At the gross margin level — before operating expenses — AGEN leads at 90. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SIGA or AGEN more undervalued right now?
On forward earnings alone, Agenus Inc.
(AGEN) trades at 1. 9x forward P/E versus 2. 8x for SIGA Technologies, Inc. — 0. 9x cheaper on a one-year earnings basis.
08Which pays a better dividend — SIGA or AGEN?
In this comparison, SIGA (12.
8% yield) pays a dividend. AGEN does not pay a meaningful dividend and should not be held primarily for income.
09Is SIGA or AGEN better for a retirement portfolio?
For long-horizon retirement investors, SIGA Technologies, Inc.
(SIGA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 12. 8% yield, +722. 2% 10Y return). Agenus Inc. (AGEN) carries a higher beta of 2. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SIGA: +722. 2%, AGEN: -93. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SIGA and AGEN?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SIGA is a small-cap deep-value stock; AGEN is a small-cap quality compounder stock. SIGA pays a dividend while AGEN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.